Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Johnstone

Showing results (171-180 of 352) with videos related to

Pageof 36
Sort By:
Clinical Epigenetics|January 29, 2015
Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemiaJessica M Salmon, Michael Bots, Eva Vidacs, et al.
Texas Heart Institute Journal|July 9, 2021
Venovenous Extracorporeal Membrane Oxygenation to Facilitate Removal of Endobronchial TumorsBryan Miles, Lucian A Durham, Jonathan Kurman, et al.
Journal of Neuroimmunology|February 1, 1992
Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activationD L Gordon, T A Sadlon, S L Wesselingh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2008
Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune responseJohn Stagg, Janelle Sharkey, Sandra Pommey, et al.
JAMA Oncology|June 1, 2018
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung CancerRobert D Timmerman, Chen Hu, Jeff M Michalski, et al.
Leukemia|January 12, 2017
HDAC3 activity is required for initiation of leukemogenesis in acute promyelocytic leukemiaP Mehdipour, F Santoro, O A Botrugno, et al.
Biochemical and Biophysical Research Communications|December 8, 2004
Biochemical and growth regulatory activities of the HIN-200 family member and putative tumor suppressor protein, AIM2Kim S Cresswell, Christopher J P Clarke, Jacob T Jackson, et al.
Molecular and Cellular Biology|August 29, 2003
Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motifGrant A Darnell, Toni M Antalis, Ricky W Johnstone, et al.
Oncogene|May 19, 2015
Scribble acts as an oncogene in Eμ-myc-driven lymphomaE D Hawkins, J Oliaro, K M Ramsbottom, et al.
Journal of Cellular Biochemistry|April 12, 2003
Critical role of the transcription factor AP-1 for the constitutive and interferon-induced expression of IFI 16C J P Clarke, V Apostolidis, L L P Hii, et al.
Pageof 36

Showing results (171-180 of 352) with videos related to

Sort By:
Pageof 36
Clinical Epigenetics|January 29, 2015
Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemiaJessica M Salmon, Michael Bots, Eva Vidacs, et al.
Texas Heart Institute Journal|July 9, 2021
Venovenous Extracorporeal Membrane Oxygenation to Facilitate Removal of Endobronchial TumorsBryan Miles, Lucian A Durham, Jonathan Kurman, et al.
Journal of Neuroimmunology|February 1, 1992
Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activationD L Gordon, T A Sadlon, S L Wesselingh, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2008
Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune responseJohn Stagg, Janelle Sharkey, Sandra Pommey, et al.
JAMA Oncology|June 1, 2018
Long-term Results of Stereotactic Body Radiation Therapy in Medically Inoperable Stage I Non-Small Cell Lung CancerRobert D Timmerman, Chen Hu, Jeff M Michalski, et al.
Leukemia|January 12, 2017
HDAC3 activity is required for initiation of leukemogenesis in acute promyelocytic leukemiaP Mehdipour, F Santoro, O A Botrugno, et al.
Biochemical and Biophysical Research Communications|December 8, 2004
Biochemical and growth regulatory activities of the HIN-200 family member and putative tumor suppressor protein, AIM2Kim S Cresswell, Christopher J P Clarke, Jacob T Jackson, et al.
Molecular and Cellular Biology|August 29, 2003
Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motifGrant A Darnell, Toni M Antalis, Ricky W Johnstone, et al.
Oncogene|May 19, 2015
Scribble acts as an oncogene in Eμ-myc-driven lymphomaE D Hawkins, J Oliaro, K M Ramsbottom, et al.
Journal of Cellular Biochemistry|April 12, 2003
Critical role of the transcription factor AP-1 for the constitutive and interferon-induced expression of IFI 16C J P Clarke, V Apostolidis, L L P Hii, et al.
Pageof 36